John W. Bristol & Co’s Merck MRK Stock Holding History

John W. Bristol & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,685	Closed	-$209K	–	71
2024 Q2	$209K	Buy	+1,685	New	+$217K	﹤0.01%	62
2023 Q4	–	Sell	-13,500	Closed	-$1.39M	–	73
2023 Q3	$1.39M	Hold	13,500	–	–	0.03%	50
2023 Q2	$1.56M	Sell	13,500 -10,334	-43%	-$1.17M	0.03%	50
2023 Q1	$2.54M	Hold	23,834	–	–	0.05%	49
2022 Q4	$2.64M	Sell	23,834 -124	-0.5%	-$12.7K	0.06%	48
2022 Q3	$2.06M	Buy	23,958 +124	+0.5%	+$11.1K	0.05%	50
2022 Q2	$2.17M	Hold	23,834	–	–	0.05%	47
2022 Q1	$1.96M	Hold	23,834	–	–	0.04%	47
2021 Q4	$1.83M	Hold	23,834	–	–	0.03%	51
2021 Q3	$1.79M	Hold	23,834	–	–	0.03%	50
2021 Q2	$1.85M	Sell	23,834 -1,144	-5%	-$85.1K	0.03%	50
2021 Q1	$1.84M	Buy	24,978 +14,148	+131%	+$1.04M	0.04%	48
2020 Q4	$845K	Hold	10,830	–	–	0.02%	53
2020 Q3	$857K	Buy	+10,830	New	+$848K	0.02%	51

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

John W. Bristol & Co's MRK Position: Q3 2024 in Review

John W. Bristol & Co sold out of Merck (MRK) in Q3 2024, closing a stake of 1,685 shares — an estimated $209K sold.

John W. Bristol & Co first reported a position in MRK in Q3 2020 and held it in 14 quarters. The position peaked at $2.64M in Q4 2022. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

John W. Bristol & Co reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
John W. Bristol & Co sold 1,685 Merck shares in Q3 2024, an estimated $209K.
John W. Bristol & Co first reported a position in Merck in Q3 2020 and held it in 14 quarters.
John W. Bristol & Co's Merck position peaked at $2.64M in Q4 2022.
3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on John W. Bristol & Co's 13F filing for Q3 2024, filed 14 Nov 2024.